FDA cracks down on Alzheimer's treatments, 17 firms targeted for false claims

The U.S. Food and Drug Administration (FDA) said Monday it sent warning letters to 17 firms that are “illegally selling” more than 58 products that claim to prevent, treat or cure Alzheimer’s disease and other serious health conditions. The FDA warns that the products, which are often sold online through websites and social media platforms, have not been reviewed by them and “are not proven safe and effective” to treat the diseases as marketed.

“Four hostile newspapers are more to be feared than a thousand bayonets...” ― Napoléon Bonaparte